250 Participants Needed

Calcium Carbonate for Labor Induction

JK
EM
Overseen ByEmily Malloy, PhD, CNM
Age: 18+
Sex: Female
Trial Phase: Academic
Sponsor: Aurora Health Care
Must be taking: Oxytocin
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 2 JurisdictionsThis treatment is already approved in other countries

Trial Summary

What is the purpose of this trial?

The investigators aim to evaluate the safety and efficacy of administering calcium carbonate to laboring participants undergoing labor inductions. The investigators hypothesize that calcium carbonate is a low-risk preventative measure to decrease oxytocin induction time and dosage, decrease the rate of labor dystocia, decrease the rate of cesarean deliveries, and demonstrate no differences in maternal or neonatal safety outcomes.

Do I have to stop taking my current medications for this trial?

The trial protocol does not specify if you need to stop taking your current medications. However, if you have a known contraindication to calcium carbonate, such as certain kidney or calcium-related conditions, you may not be eligible to participate.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What data supports the idea that Calcium Carbonate for Labor Induction is an effective treatment?

The available research shows that there is no clear evidence supporting the effectiveness of Calcium Carbonate for labor induction. While some clinicians have shared stories of its use for labor issues, the studies mainly discuss its role in muscle contractions and other related areas. However, no direct evidence confirms its success in preventing or treating labor problems. Other treatments, like calcium gluconate and sodium bicarbonate, have been studied more for labor issues, suggesting a need for more research on Calcium Carbonate.12345

What data supports the effectiveness of the drug Calcium Carbonate for labor induction?

There is anecdotal evidence from clinicians suggesting that calcium carbonate may help with labor dystocia (difficulty in labor), and some studies indicate that calcium can influence uterine muscle contractions, which might support its potential use in labor induction.12345

What safety data exists for using calcium carbonate in labor induction?

Existing safety data for calcium carbonate, often used as an antacid, includes reports of hypercalcemia-induced pancreatitis and calcium-alkali syndrome from excessive intake. These conditions can lead to serious complications such as renal impairment and staghorn calculus formation. Additionally, excessive intake can cause issues during medical procedures, such as colonoscope malfunction. While calcium carbonate is being explored for its potential benefits in labor induction, particularly in preventing labor dystocia, no direct evidence supports its safety or efficacy for this use. Therefore, caution is advised, and further research is needed to establish its safety profile in this context.15678

Is calcium carbonate safe for use in humans?

Calcium carbonate is generally safe for humans, but excessive intake can lead to serious issues like hypercalcemia (high calcium levels in the blood), which can cause kidney problems and other complications. It's important to follow recommended dosages and consult with a healthcare provider, especially during pregnancy or when taking other medications.15678

Is the drug Calcium Carbonate a promising treatment for labor induction?

The provided research articles do not mention Calcium Carbonate as a treatment for labor induction. Therefore, there is no evidence from these sources to suggest that Calcium Carbonate is a promising drug for this purpose.910111213

How does the drug Calcium Carbonate differ from other labor induction methods?

Calcium Carbonate is unique for labor induction as it is traditionally used for conditions like heartburn and indigestion, unlike common labor induction drugs such as prostaglandins or oxytocin. This makes its use in labor induction novel, as it is not a standard treatment for this purpose.910111213

Research Team

MF

Marie Forgie, DO

Principal Investigator

Wake Forest University Health Sciences

Eligibility Criteria

This trial is for pregnant individuals who are about to undergo labor induction. The specific details on eligibility criteria were not provided, so it's important to consult with the study organizers for more information.

Inclusion Criteria

Singleton gestation
I will receive a standard dose of oxytocin for induction.
I can speak and read in English or Spanish.
See 3 more

Exclusion Criteria

Known need for cesarean section prior to induction of labor
Inability to tolerate oral intake (i.e., nausea/vomiting)
Known allergy to calcium carbonate
See 2 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive calcium carbonate (500mg every 4 hours) plus standard-dose oxytocin for labor induction

Duration of induction with oxytocin until delivery

Follow-up

Participants are monitored for safety and effectiveness after treatment, including blood loss and postpartum hemorrhage

24 hours post-delivery

Neonatal Monitoring

Neonates are monitored for composite adverse outcomes until discharge

3 days

Treatment Details

Interventions

  • Calcium Carbonate
Trial Overview The trial is testing if calcium carbonate can help during labor induction by reducing the time and dosage of oxytocin needed, lowering the chances of difficult labor (dystocia), and cutting down cesarean deliveries without harming mother or baby.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Prospective Treatment GroupExperimental Treatment1 Intervention
Patients receive calcium carbonate (500mg every 4 hours, per standardized treatment protocol) plus standard-dose oxytocin for labor induction
Group II: Retrospective Historical Control GroupActive Control1 Intervention
Patients who presented for induction at the same institution within the previous three years and received standard-dose oxytocin alone for labor induction and were not treated with calcium carbonate

Calcium Carbonate is already approved in United States, European Union for the following indications:

🇺🇸
Approved in United States as Calcium Carbonate for:
  • Heartburn relief
  • Indigestion relief
  • Calcium supplement
🇪🇺
Approved in European Union as Calcium Carbonate for:
  • Heartburn relief
  • Indigestion relief
  • Calcium supplement

Find a Clinic Near You

Who Is Running the Clinical Trial?

Aurora Health Care

Lead Sponsor

Trials
46
Recruited
16,400+

Wake Forest University Health Sciences

Lead Sponsor

Trials
1,432
Recruited
2,506,000+

Findings from Research

A case study of a pregnant woman revealed that excessive consumption of calcium carbonate for GERD led to hypercalcemia and pancreatitis, highlighting a serious complication of this common treatment.
The patient's condition improved after delivery and appropriate medical management, indicating that while calcium carbonate can be effective for GERD, it must be used cautiously to avoid potential adverse effects during pregnancy.
Hypercalcemia-Induced Pancreatitis in Pregnancy Following Calcium Carbonate Ingestion.Trezevant, MS., Winton, JC., Holmes, AK.[2022]
In a trial involving 1106 patients in labor, Andursil was preferred for its taste compared to Magnesium Trisilicate Co, indicating better patient satisfaction.
Despite the preference for Andursil, both treatments had similar rates of nausea and vomiting, suggesting that palatability does not affect the incidence of these side effects.
An antacid comparison trial.Atkinson, RE.[2013]
Cimetidine, an H2-receptor antagonist, effectively increased intragastric pH and reduced gastric acidity in parturients, with 80% of patients receiving emergency anesthesia showing a pH higher than 2.5 after treatment.
In a second trial, combining cimetidine with sodium citrate resulted in all elective cesarean section patients having low gastric volumes and pH greater than 2.5, indicating a safe approach to managing gastric contents before anesthesia, with no noted side effects for mothers or infants.
Use of cimetidine as an oral antacid in obstetric anesthesia.Johnston, JR., Moore, J., McCaughey, W., et al.[2013]

References

Hypercalcemia-Induced Pancreatitis in Pregnancy Following Calcium Carbonate Ingestion. [2022]
An antacid comparison trial. [2013]
Use of cimetidine as an oral antacid in obstetric anesthesia. [2013]
Excessive calcium ingestion leading to milk-alkali syndrome. [2013]
Calcium Carbonate as a Potential Intervention to Prevent Labor Dystocia: Narrative Review of the Literature. [2023]
Excessive Tums Intake Can Cause Colonoscope Malfunction. [2020]
Lessons of the month: Over-the-counter antacids causing hypercalcaemia: The emergence of calcium-alkali syndrome. [2021]
Calcium carbonate antacids alter esophageal motility in heartburn sufferers. [2019]
[Pharmacological induction of labour: benefits and risks]. [2013]
Induction of labour by balloon catheter with extra-amniotic saline infusion (BCEAS): a randomised comparison with PGE2 vaginal pessaries. [2019]
[Treatment of Chronic Functional Constipation during Pregnancy and Lactation]. [2016]
12.United Statespubmed.ncbi.nlm.nih.gov
Methods of cervical ripening and labor induction. [2019]
13.United Statespubmed.ncbi.nlm.nih.gov
The use of breast stimulation to ripen the cervix in term pregnancies. [2019]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security